Kurma Partners — 2011 Investments

1 investments dated 2011 · listed companies and verified rows first · show all

AM Pharmaam-pharma.com inSep 2011 · $40M

AM-Pharma develops ilofotase alfa, a recombinant alkaline phosphatase enzyme therapy, and is studying it as a treatment for adults with hypophosphatasia (HPP), a rare inherited metabolic bone disease.

BiotechHealthtech

Co-investorsAndera Partners Ysios Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.